i 杜仲 · iDuZhong杜仲名人堂 · HALL OF FAME 全部人物All
金金国章

金国章

Jin Guozhang

中科院院士、上海药物所研究员
CAS Academician and Researcher at the Shanghai Institute of Materia Medica
现代科学
Modern Science
“安贫乐道、志在前程、为国争光。”

人物简介

1956年发表杜仲毒性与降压实验治疗论文的我国首批杜仲现代药理研究者

事迹

金国章(1927-2019),浙江永康人,1952年毕业于浙江大学理学院药学系后分配到中国科学院上海药物研究所。作为丁光生教授科研团队的新成员,他参与降压药研究,于1956年在《生理学报》同期发表藜芦降压与杜仲毒性实验治疗两篇论文,后者是我国最早用现代实验药理学方法研究杜仲的文献之一。

该研究对大白鼠、豚鼠、兔、狗进行杜仲煎剂亚急性毒性试验,并以3只肾型高血压狗连续4周灌胃给药观察降压效果,得出杜仲治疗剂量毒性很小、降压作用温和的科学结论,为后来杜仲降压研究与杜仲茶开发提供了最早的现代药理依据。

重要活动 / 事件

  • 1956年5月任中国科学院药物研究所助理研究员,同年12月杜仲研究论文发表于《生理学报》
  • 1956年夏从高血压组转入神经药理组,开启延胡索研究
  • 2007年7月中科院上海药物所为其举办八十华诞神经科学研讨会

代表贡献

  • 1956年与丁光生合作在《生理学报》20卷4期发表《治疗高血压药物的研究——Ⅱ.中药杜仲的毒性和实验治疗》
  • 首次以肾型高血压狗模型系统评价杜仲煎剂的降压作用与亚急性毒性,证实其毒性很小
  • 该文为其人生中最早的两篇学术论文之一,也是上海药物所药理实验室最早的研究成果
  • 后以延胡索多巴胺药理研究著称,2001年当选中国科学院院士,2002年获何梁何利奖
“Content in poverty yet devoted to his calling, aspiring to great achievements, and winning honor for the nation.”

Profile

One of China's first modern pharmacological researchers of Eucommia, who published a 1956 paper on its toxicity and experimental antihypertensive therapy

Story

Jin Guozhang (1927–2019), a native of Yongkang, Zhejiang, graduated from the Department of Pharmacy, College of Science, Zhejiang University in 1952 and was assigned to the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. As a new member of Professor Ding Guangsheng's research team, he participated in antihypertensive drug research and in 1956 published two papers in the same issue of Acta Physiologica Sinica—one on the antihypertensive effect of Veratrum and one on the toxicity and experimental therapy of Eucommia—the latter being among China's earliest studies of Eucommia using modern experimental pharmacology.

The study conducted subacute toxicity tests of Eucommia decoction in rats, guinea pigs, rabbits, and dogs, and administered the decoction by gavage to three renal hypertensive dogs for four consecutive weeks to observe antihypertensive effects. It concluded that Eucommia has very low toxicity at therapeutic doses and a mild antihypertensive action, providing the earliest modern pharmacological basis for later research on Eucommia for hypertension and the development of Eucommia tea.

Milestones

  • Appointed assistant researcher at the Institute of Materia Medica, Chinese Academy of Sciences, in May 1956; his Eucommia paper was published in Acta Physiologica Sinica in December of that year
  • Transferred from the hypertension group to the neuropharmacology group in the summer of 1956, beginning his research on Corydalis yanhusuo
  • In July 2007, the Shanghai Institute of Materia Medica, CAS, held a neuroscience symposium in honor of his 80th birthday

Key Contributions

  • In 1956, co-authored with Ding Guangsheng 'Studies on Drugs for the Treatment of Hypertension—II. Toxicity and Experimental Therapy of the Chinese Drug Eucommia' in Acta Physiologica Sinica, Vol. 20, No. 4
  • First to systematically evaluate the antihypertensive effect and subacute toxicity of Eucommia decoction using a renal hypertensive dog model, confirming its very low toxicity
  • The paper was one of the first two academic papers of his career and among the earliest research outputs of the pharmacology laboratory at the Shanghai Institute of Materia Medica
  • Later renowned for his research on the dopamine pharmacology of Corydalis yanhusuo; elected Academician of the Chinese Academy of Sciences in 2001 and received the Ho Leung Ho Lee Prize in 2002
QR · 金国章
长按识别二维码 · 访问「杜仲名人堂」Scan to open the Eucommia Hall of Fame
i 杜仲 · 杜仲全产业链大数据平台i DuZhong · Eucommia Full-Chain Data Platform
iduzhong.factorydossier.com
查看全部人物All figures 微信点右上角 ··· 转发;或长按二维码识别访问In WeChat tap ··· to share; long-press the QR to open
← 翟文俊← Zhai Wenjun 进入 i 杜仲全产业链数据平台 →Enter the i DuZhong platform → 过晋源 →Guo Jinyuan →
i 杜仲 · 杜仲全产业链大数据平台 · 杜仲名人堂
人物事迹依据公开权威资料整理;补录人物或提供照片:[email protected]
i DuZhong · Eucommia Full-Chain Big Data Platform · Hall of Fame
Profiles compiled from public sources. To contribute: [email protected]